Shaanxi
002864.SZShaanxi Panlong Pharmaceutical Group Limited By Share Ltd Price (002864.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
97,727,590
(4.6542)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 226,614,469 | 245,695,161 | 256,097,405 | 305,425,505 | 376,791,557 | 489,447,811 | 610,636,793 | 670,312,981 | 887,484,877 | 974,293,135 | 980,828,104 |
| Net Income | 32,894,426 | 40,072,403 | 42,638,231 | 39,527,736 | 43,718,975 | 64,681,884 | 71,778,896 | 79,115,001 | 93,169,906 | 101,163,536 | 110,432,177 |
| FCF USD | -5,117,622 | 16,131,795 | -4,457,315 | 44,935,327 | 5,001,078 | 26,782,654 | 34,335,841 | 21,057,889 | 35,358,973 | 69,526,646 | 41,534,685 |
| OCF USD | 25,433,841 | 48,555,475 | 40,620,729 | 61,991,436 | 28,449,113 | 46,846,106 | 67,886,531 | 92,238,027 | 116,035,587 | 125,362,160 | 104,047,780 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.70 | 0.44 | 0.27 | 0.02 |
| D/E | 0.09 | 0.16 | 0.07 | 0.06 | 0.01 | 0.00 | 0.00 | 0.09 | 0.13 | 0.42 | 0.07 |
| CA/CL | 1.79 | 1.77 | 1.88 | 1.96 | 3.03 | 3.20 | 2.94 | 2.51 | 2.19 | 1.64 | 3.49 |
| TA/TL | 2.60 | 2.59 | 3.00 | 2.86 | 3.82 | 3.97 | 3.65 | 2.72 | 2.54 | 1.96 | 3.70 |
| Total Debt | 20,000,000 | 40,000,000 | 20,000,000 | 20,000,000 | 3,000,000 | 0 | 0 | 63,344,227 | 106,693,064 | 393,702,578 | 102,493,637 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 12.35% | 12.46% | 12.94% | 10.33% | 7.59% | 9.01% | 10.69% | 9.84% | 10.35% | 10.06% | 6.67% |
| ROE | 15.55% | 16.32% | 14.79% | 12.06% | 7.87% | 10.58% | 10.64% | 10.98% | 11.77% | 10.88% | 7.13% |
| ROA | 0.00% | 9.69% | 9.85% | 7.85% | 5.81% | 7.91% | 7.73% | 6.98% | 7.11% | 5.34% | 5.25% |
| NM % | 14.52% | 16.31% | 16.65% | 12.94% | 11.60% | 13.22% | 11.75% | 11.80% | 10.50% | 10.38% | 11.26% |
| FCF / R% | 0.00% | 6.57% | -1.74% | 14.71% | 1.33% | 5.47% | 5.62% | 3.14% | 3.98% | 7.14% | 4.23% |
| FCF / NI% | -15.56% | 41.47% | -10.44% | 113.53% | 11.44% | 41.41% | 47.84% | 25.97% | 37.39% | 67.41% | 37.24% |
| Operating Margin (OM) | 0.00 | 0.26 | 0.40 | 0.45 | 0.47 | 0.47 | 0.47 | 0.51 | 0.47 | 0.51 | 0.59 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.51 | 0.62 | 0.66 | 0.61 | 0.65 | 0.75 | 0.83 | 0.92 | 1.09 | 1.18 | 1.15 |
| SPS | 3.51 | 3.80 | 3.96 | 4.71 | 5.60 | 5.68 | 7.05 | 7.79 | 10.37 | 11.39 | 10.21 |
| OCPS | 0.39 | 0.75 | 0.63 | 0.96 | 0.42 | 0.54 | 0.78 | 1.07 | 1.36 | 1.47 | 1.08 |
| FCPS | -0.08 | 0.25 | -0.07 | 0.69 | 0.07 | 0.31 | 0.40 | 0.24 | 0.41 | 0.81 | 0.43 |
| BVPS | 3.27 | 3.81 | 4.47 | 5.06 | 8.26 | 7.09 | 7.78 | 8.55 | 9.44 | 11.08 | 16.15 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.51 | 0.62 | 0.66 | 0.61 | 0.65 | 0.75 | 0.83 | 0.92 | 1.09 | 1.18 | 1.15 |
| CAGR-SPS | 3.51 | 3.80 | 3.96 | 4.71 | 5.60 | 5.68 | 7.05 | 7.79 | 10.37 | 11.39 | 10.21 |
| CAGR-OCPS | 0.39 | 0.75 | 0.63 | 0.96 | 0.42 | 0.54 | 0.78 | 1.07 | 1.36 | 1.47 | 1.08 |
| CAGR-FCPS | -0.08 | 0.25 | -0.07 | 0.69 | 0.07 | 0.31 | 0.40 | 0.24 | 0.41 | 0.81 | 0.43 |
| CAGR-BVPS | 3.27 | 3.81 | 4.47 | 5.06 | 8.26 | 7.09 | 7.78 | 8.55 | 9.44 | 11.08 | 16.15 |